What Researchers Did
Researchers conducted a review of existing literature to evaluate the role of hyperbaric oxygen therapy (HBOT) in treating refractory wounds of rare etiologies.
What They Found
The review included three case series and four case reports involving 63 participants with severe, non-healing ulcers. Some evidence suggested that hyperbaric oxygen therapy (HBOT) might improve wound healing rates by increasing nitric oxide levels and endothelial progenitor cells, and could also reduce pain in these ulcers.
What This Means for Canadian Patients
For Canadian patients with rare, non-healing wounds, hyperbaric oxygen therapy (HBOT) might offer a potential treatment option to aid healing and reduce pain. However, given the limited evidence, patients should discuss this therapy with their healthcare providers as part of a comprehensive wound care plan.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The review was limited by the inclusion of only case series and case reports, highlighting the need for robust randomized controlled trials to establish HBOT's true efficacy.